| Dr Kurt F Bruckmeier, MD | |
|
101 Asbury Cir, Hattiesburg, MS 39402-1302 | |
| (601) 268-5200 | |
| (601) 268-5211 |
| Full Name | Dr Kurt F Bruckmeier |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 42 Years |
| Location | 101 Asbury Cir, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083610117 | NPI | - | NPPES |
| 00016251 | Medicaid | MS | |
| P00064618 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 09945 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Hospice Of Southern Mississippi, Llc | Hattiesburg, MS | Hospice |
| Merit Health Wesley | Hattiesburg, MS | Hospital |
| Anderson Regional Medical Ctr | Meridian, MS | Hospital |
| Laird Hospital Inc | Union, MS | Hospital |
| Hattiesburg Health & Rehab Center | Hattiesburg, MS | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospitalist Services Of Meridian Pa | 3274818042 | 47 |
| Wesley Physician Services Llc | 2466559851 | 40 |
News Archive
To determine whether new medicines are safe and effective for humans, researchers must first test them in animals, which is costly and time-consuming, as well as ethically challenging.
In West Virginia, where colorectal cancer is the second-deadliest type of cancer, half of all colorectal cancers elude diagnosis until they have already grown beyond the colon. With Medicaid expansion, more West Virginians now have health insurance for cancer screening, yet many barriers to screening persist.
An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
The first known patient cases using magnetic resonance-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat prostate cancer recurrence after surgical removal of the prostate gland were presented by physicians at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa. Many of these patients have also failed salvage radiation treatment and are often presented with limited therapeutic options. MR-guided focal therapy offers a new treatment choice for patients because of the improved detection of early prostate cancer recurrences best seen with MR imaging.
› Verified 6 days ago
| Entity Name | Vicksburg Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629084058 PECOS PAC ID: 4688575129 Enrollment ID: O20040213000299 |
News Archive
To determine whether new medicines are safe and effective for humans, researchers must first test them in animals, which is costly and time-consuming, as well as ethically challenging.
In West Virginia, where colorectal cancer is the second-deadliest type of cancer, half of all colorectal cancers elude diagnosis until they have already grown beyond the colon. With Medicaid expansion, more West Virginians now have health insurance for cancer screening, yet many barriers to screening persist.
An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
The first known patient cases using magnetic resonance-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat prostate cancer recurrence after surgical removal of the prostate gland were presented by physicians at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa. Many of these patients have also failed salvage radiation treatment and are often presented with limited therapeutic options. MR-guided focal therapy offers a new treatment choice for patients because of the improved detection of early prostate cancer recurrences best seen with MR imaging.
› Verified 6 days ago
| Entity Name | Wesley Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538200209 PECOS PAC ID: 2466559851 Enrollment ID: O20070518000496 |
News Archive
To determine whether new medicines are safe and effective for humans, researchers must first test them in animals, which is costly and time-consuming, as well as ethically challenging.
In West Virginia, where colorectal cancer is the second-deadliest type of cancer, half of all colorectal cancers elude diagnosis until they have already grown beyond the colon. With Medicaid expansion, more West Virginians now have health insurance for cancer screening, yet many barriers to screening persist.
An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
The first known patient cases using magnetic resonance-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat prostate cancer recurrence after surgical removal of the prostate gland were presented by physicians at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa. Many of these patients have also failed salvage radiation treatment and are often presented with limited therapeutic options. MR-guided focal therapy offers a new treatment choice for patients because of the improved detection of early prostate cancer recurrences best seen with MR imaging.
› Verified 6 days ago
| Entity Name | Keystone Hospitalist Services Of Ms Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932447968 PECOS PAC ID: 7517103864 Enrollment ID: O20130411000527 |
News Archive
To determine whether new medicines are safe and effective for humans, researchers must first test them in animals, which is costly and time-consuming, as well as ethically challenging.
In West Virginia, where colorectal cancer is the second-deadliest type of cancer, half of all colorectal cancers elude diagnosis until they have already grown beyond the colon. With Medicaid expansion, more West Virginians now have health insurance for cancer screening, yet many barriers to screening persist.
An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
The first known patient cases using magnetic resonance-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat prostate cancer recurrence after surgical removal of the prostate gland were presented by physicians at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa. Many of these patients have also failed salvage radiation treatment and are often presented with limited therapeutic options. MR-guided focal therapy offers a new treatment choice for patients because of the improved detection of early prostate cancer recurrences best seen with MR imaging.
› Verified 6 days ago
| Entity Name | Hospitalist Services Of Meridian Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639629777 PECOS PAC ID: 3274818042 Enrollment ID: O20170316002383 |
News Archive
To determine whether new medicines are safe and effective for humans, researchers must first test them in animals, which is costly and time-consuming, as well as ethically challenging.
In West Virginia, where colorectal cancer is the second-deadliest type of cancer, half of all colorectal cancers elude diagnosis until they have already grown beyond the colon. With Medicaid expansion, more West Virginians now have health insurance for cancer screening, yet many barriers to screening persist.
An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
The first known patient cases using magnetic resonance-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat prostate cancer recurrence after surgical removal of the prostate gland were presented by physicians at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa. Many of these patients have also failed salvage radiation treatment and are often presented with limited therapeutic options. MR-guided focal therapy offers a new treatment choice for patients because of the improved detection of early prostate cancer recurrences best seen with MR imaging.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kurt F Bruckmeier, MD 101 Asbury Cir, Hattiesburg, MS 39402-1302 Ph: (601) 268-5200 | Dr Kurt F Bruckmeier, MD 101 Asbury Cir, Hattiesburg, MS 39402-1302 Ph: (601) 268-5200 |
News Archive
To determine whether new medicines are safe and effective for humans, researchers must first test them in animals, which is costly and time-consuming, as well as ethically challenging.
In West Virginia, where colorectal cancer is the second-deadliest type of cancer, half of all colorectal cancers elude diagnosis until they have already grown beyond the colon. With Medicaid expansion, more West Virginians now have health insurance for cancer screening, yet many barriers to screening persist.
An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report Dana-Farber Cancer Institute researchers in the November issue of Cancer Cell.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
The first known patient cases using magnetic resonance-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat prostate cancer recurrence after surgical removal of the prostate gland were presented by physicians at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa. Many of these patients have also failed salvage radiation treatment and are often presented with limited therapeutic options. MR-guided focal therapy offers a new treatment choice for patients because of the improved detection of early prostate cancer recurrences best seen with MR imaging.
› Verified 6 days ago
Laurie Evans Douglas, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-261-1700 Fax: 601-288-8290 | |
Dr. Charles Ramsey Mccollum Iii, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5650 Fax: 601-579-5212 | |
Porter Hudson Glover, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5680 Fax: 601-268-5778 | |
Alex Gauthier, Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 5001 Hardy St, Hattiesburg, MS 39402 Phone: 601-268-8000 | |
Grettel Rodriguez Garcia, Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 31 Woodstone Dr, Hattiesburg, MS 39402 Phone: 347-342-2441 | |
Ms. Manal Mohammad Abdur Rahman, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7 Medical Blvd, Hattiesburg, MS 39401 Phone: 601-296-2990 Fax: 601-296-2860 | |
Dr. Vashishtha Patel, DO Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 5001 Hardy St, Hattiesburg, MS 39402 Phone: 704-733-7499 |